Cross-sectional epidemiological study to evaluate the cardiovascular profile of a cohort of blood donors

Blood Transfusion

Volumn 5, Issue 3, 2007, Pages 153-157

  Longo, Marcella ^a   Lucci, Carla ^a   Marconi, Maurizio ^a   Cremonesi, Giovanna ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Absolute global cardiovascular risk; Blood donors; Cardiovascular prevention

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD DONOR; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; LIFESTYLE MODIFICATION; MALE; RISK ASSESSMENT; SCORING SYSTEM;

EID: 47749148122     PISSN: 17232007     EISSN: None     Source Type: Journal    
DOI: 10.2450/2007.0020-07     Document Type: Article

References (14)

1. Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364: 937-52.
2. Shurtleff D. Some characteristics related to the incidence of cardiovascular disease and death: Framingham study, 16 years follow up. In: Kannell WB, Gordon T, eds. The Framingham study. An epidemiological investigation of cardiovascular diseases. Section 26. US Government Printing Office no 0-414-297 Washington DC, 1971.
3. Anderson KM, Wilson PWF, Odell PM et al. An updated coronary risk profile. A statment for health professionals. Circulation 1991; 83:356-62.
4. Giampaoli S, Palmieri L, Mattiello A, et al. Definition of high risk individuals to optimise strategies for primary prevention of cardiovascular diseases. Nutr Metab Cardiovasc Dis 2005; 15: 79-85.
5. Grundy SM, Bazzarre T, Cleeman J, et al. Prevention Conference V. Beyond secondary prevention: identifying the high-risk patient for primary prevention. Circulation 2000; 101: e3-e11.
6. Lloyd-Jones DM, Lu Tian. Predicting cardiovascular risk. So what do we do now? Arch Intern Med 2006; 166: 1342-3.
7. Giampaoli S, Palmieri L, Panico S, et al. Favorable cardiovascular risk profile (low risk) and 10-year stroke incidence in women and men: findings from 12 Italian population samples. Am J Epidemiol 2006; 163: 893-902.
8. Ferrario M, Chiodini P, Chamberless LE, et al. Prediction of coronary events in a low incidence population. Assessing accuracy of the CUORE Cohort Study prediction equation. Int J Epid 2005; 34: 413-21.
9. Palmieri L, Donfrancesco C, Giampaoli S, et al. Favorable cardiovascular risk profile and 10-year coronary heart disease incidence in women and men: results from the Progetto CUORE. Eur J Cardiovasc Prev Rehabil 2006; 13: 562-70.
10. Pearson TA. Population benefits of cholesterol reduction: epidemiology, economics, and ethics. Am J Cardiol 2000: 85; 20E-23E.
11. Menotti A, Puddu PE, Lanti M. Comparison of the Framingham risk function-based coronary chart with risk function from an Italian population study. Eur Heart J 2000; 21: 365-70.
12. De Backer G, Ambrosioni E, Borch-Johnsen K, et al. European Guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur J Cardiovasc Prev Rehabil 2003, 10: S1-S10.
13. Bigazzi R, Binachi S, Batini V, et al. Metabolic risk factors and markers of cardiovascular and renal damage in overweight subjects. Am J Hypertens 2006; 19: 426-31.
14. Grundy SM, Pasternak R, Greenland P, et al. Assessment of cardiovascular risk by use of multiple risk factor assessment equations. Circulation 1999; 100: 1481-92.